Federal inspectors found the facility violated medication safety regulations during a December 23 complaint investigation. The resident had been self-administering Ipratropium Bromide nasal spray three times daily for seasonal allergic rhinitis, yet staff never evaluated her capacity for self-medication or documented physician approval.
The 77-bed facility's own policy requires that residents "may self-administer their own medications only if the attending physician, in conjunction with the interdisciplinary care planning team, has determined that they have the decision-making capacity to do so safely."
None of that happened for the resident, identified as R6 in the inspection report.
When a registered nurse arrived to give morning medications on December 23, she told inspectors: "I don't have the nasal spray in the cart because usually the other nurses leave the nasal spray in the resident's room because she can do it by herself."
The resident retrieved the medication from a white box on her bedside table and administered it in front of the nurse. She demonstrated her technique to inspectors later that morning, explaining how she held one nostril closed while spraying in the other.
"That's my nasal spray," she told inspectors at 8:02 AM. "They leave it there because I have been using nasal spray for a long time and I can do it on my own."
The resident had been admitted to the facility with multiple health conditions including fibromyalgia, anxiety disorder, chronic kidney disease, and hypertension. Her December 16 care plan noted she had "demonstrated a decreased ability to perform activities of daily living related to impaired mobility" and required setup assistance from staff for eating. She wore glasses and hearing aids.
Despite these documented limitations, no assessment appears anywhere in her medical record regarding self-administration of medications.
Inspectors reviewed her admission record, care plans, assessments, progress notes, physician orders, and medication administration records. The required evaluation was missing from all documentation.
The Director of Nursing acknowledged the facility's standard procedures during an afternoon interview on December 23. When residents can administer their own medications, she explained, "this would be documented in the assessments tab of the EMR, it will also be care planned, and they had an Interdisciplinary Team meeting progress note stating that the resident was able to self-administer their own medications."
The resident's physician had ordered the nasal spray on December 16 with a start date that same day. But the order contained no authorization for self-administration, and no interdisciplinary team meeting occurred to evaluate her capacity.
Federal regulations require nursing homes to ensure residents receive medications safely. Self-administration represents a significant responsibility that demands careful assessment of cognitive ability, physical dexterity, and understanding of proper dosing and timing.
The facility's April 2019 policy emphasizes that "medications are administered in a safe and timely manner, and as prescribed." It specifically requires physician determination "in conjunction with the interdisciplinary care planning team" before allowing self-administration.
This systematic failure created potential risks. Without proper assessment, staff couldn't verify the resident understood correct dosing, timing, or potential side effects. They couldn't confirm she had the physical ability to administer the medication properly or the cognitive capacity to remember when she had already taken it.
The nasal spray contained Ipratropium Bromide, a prescription medication that requires precise dosing. Two sprays in each nostril three times daily represents a specific medical regimen that demands adherence to prevent under-treatment or overdose.
The inspection revealed a pattern of informal decision-making that bypassed required safety protocols. Nurses collectively decided to leave the medication in the resident's room based on their assumption she could "do it by herself," without conducting the formal evaluation process their own policies required.
The facility received a citation for minimal harm with potential for actual harm. Inspectors noted the violation affected "few" residents, suggesting the problem may not be widespread but represents a significant gap in medication safety procedures.
Oak Park Place of Nakoma operates as a skilled nursing facility in Madison's Nakoma neighborhood. The December 23 inspection occurred in response to a complaint, though the nature of that complaint was not specified in the inspection report.
The facility must submit a plan of correction detailing how it will prevent similar violations. This typically includes revised procedures for evaluating residents' capacity for self-administration, staff training on proper documentation requirements, and systems to ensure interdisciplinary team involvement in such decisions.
The resident continues to need the nasal spray for her seasonal allergic rhinitis. Whether she will be formally assessed for self-administration or have the medication returned to nursing staff control depends on the facility's corrective actions and the attending physician's determination of her actual capacity to safely manage the medication independently.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Oak Park Place of Nakoma from 2025-12-23 including all violations, facility responses, and corrective action plans.